Table 4 Distribution of serum CA-125, SUVmax, MTV, TLG and number of metabolic active peritoneal sites between complete and incomplete tumor debulking cohorts
From: Metabolic active peritoneal sites affect tumor debulking in ovarian and peritoneal cancers
Complete tumor debulking cohort | Incomplete tumor debulking cohort | p-value* | |
|---|---|---|---|
Serum CA-125 (units/mL) | 306.1 ± 422.1 | 1010.2 ± 1911.9 | 0.509 |
SUVmax | 2.4 ± 3.4 | 5.8 ± 3.4 | 0.006 |
MTV (cm3) | 27 ± 49 | 81 ± 120 | 0.013 |
TLG (cm3) | 62 ± 114 | 167 ± 190 | 0.007 |
Number of metabolic active peritoneal sites | 0.6 ± 0.8 | 2.3 ± 1.7 | 0.001 |